Carisoprodol

Carisoprodol Basic information
Product Name:Carisoprodol
Synonyms:Miolisodal;Miolisodol;Mioratrina;Mioril;Mioriodol;NCI-C56235;Nospasm;Relasom
CAS:78-44-4
MF:C12H24N2O4
MW:260.33
EINECS:201-118-7
Product Categories:API;SOMA;Aliphatics;Amines;Isotope Labeled Compounds;Intermediates & Fine Chemicals;Pharmaceuticals;Muscle Relaxants;Neurobiology;Pharmacologicals;API intermediates;ACTIVE PHARMACEUTICAL INGREDIENTS;78-44-4
Mol File:78-44-4.mol
Carisoprodol Structure
Carisoprodol Chemical Properties
Melting point 92-92°C
Boiling point 403.59°C (rough estimate)
density 1.1035 (rough estimate)
refractive index 1.4560 (estimate)
storage temp. 2-8°C
solubility Very slightly soluble in water, freely soluble in acetone, in alcohol and in methylene chloride.
form Solid
pkapKa 4.2 (Uncertain)
color White to Off-White
Water Solubility <0.1 g/100 mL at 19.5 ºC
BCS Class2/4
CAS DataBase Reference78-44-4(CAS DataBase Reference)
NIST Chemistry ReferenceCarisoprodol(78-44-4)
EPA Substance Registry SystemCarisoprodol (78-44-4)
Safety Information
Hazard Codes Xn
Risk Statements 22
Safety Statements 36
RTECS FB3325000
HS Code 29224999
Hazardous Substances Data78-44-4(Hazardous Substances Data)
ToxicityLD50 in mice, rats (mg/kg): 2340, 1320 orally; 980, 450 i.p. (Berger)
MSDS Information
ProviderLanguage
Carisoprodol English
Carisoprodol Usage And Synthesis
DescriptionCarisoprodol (CRM) (Item No. ISO60206) is a certified reference material categorized as a skeletal muscle relaxant. It also has sedative properties. Carisoprodol is regulated as a Schedule IV compound in the United States. Carisoprodol (CRM) (Item No. ISO60206) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
DescriptionCarisoprodol (Item No. 30778) is an analytical reference standard categorized as a skeletal muscle relaxant. It also has sedative properties. Carisoprodol is regulated as a Schedule IV compound in the United States. This product is intended for research and forensic applications.
Chemical PropertiesWhite Solid
OriginatorSoma,Wallace,US,1959
UsesFor the relief of discomfort associated with acute, painful, musculoskeletal conditions.
UsesCarisoprodol suppresses interneuronal action of reticular formation of the spinal cord. It is used as an adjuvant drug for loss of flexibility of skeletal muscle as well as for relieving pain caused therein. Synonyms of this drug are rela, soma, carisoma, and sanoma.
UsesMuscle relaxant (skeletal)
Carisoprodol has an onset of action of ca. 30min and a duration of 4–6h. It is administered orally. Presumably, it acts by inhibiting interneuronal activity in the spinal cord and the brainstem reticular formation. Clinically effective doses are accompanied by drowsiness or dizziness; its mechanism may involve sedation.Its CNS depressant effects are additive with those of ethanol and other psychotropic agents. Carisoprodol has a low potential for drug dependence.
Carisoprodol tablets USP

DefinitionChEBI: A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alter tion in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.
PreparationCarisoprodol is Prepared by reaction of 2-methyl-2-propyl-1,3-pro-panediol with phosgene and ammonium hydroxide, then with isopropyl isocyanate.
Manufacturing ProcessA cooled 10% solution of 1 mol of phosgene in toluene was added with stirring to a cooled solution of 1 mol of 2-methyl-2-propyl-1,3-propanediol and 2 mols of dimethylaniline also dissolved in toluene, at such a rate that the temperature of the mixture was maintained at about 25°C. The mixture was allowed to remain at this temperature for several hours, then cooled and extracted with cold 5% hydrochloric acid solution to remove the dimethylaniline. The toluene layer was dried using a suitable drying agent and the 2-methyl-2-propyl-3-hydroxypropyl chlorocarbonate used in subsequent reactions in the form of its solution in anhydrous toluene.
A quantity of solution obtained as described containing 0.1 mol of the chlorocarbonate was treated with 0.2 mol of anhydrous isopropylamine and allowed to react at ordinary room temperature. The solution was cooled, extracted with dilute hydrochloric acid and the organic layer concentrated by evaporation of the solvent. The crude monocarbamate was purified by distilling at 86° to 88°C at about 0.01 mm. It was a clear, viscous liquid.
21.7 g (0.1 mol) of N-isopropyl-2-methyl-2-propyl-3-hydroxypropylcarbamate and 7.5 g (0.11 mol) of anhydrous sodium cyanate are stirred in 200 ml anhydrous chloroform in a suitable vessel equipped with a gas inlet tube,stirrer and thermometer. While cooling the vessel, anhydrous hydrogen chloride is passed into the stirred mixture slowly for 5 hours maintaining the temperature between 0° and 5°C. Alternatively ethyl urethane in the presence of aluminum isopropylate as a catalyst may be used in place of the sodium cyanates and HCl. The mixture is then allowed to stand at room temperature overnight.
The solid material is separated by filtration and the chloroform solution concentrated to an oil under reduced pressure. The oil is dissolved in 50 ml of trichloroethylene, the solution treated with charcoal, filtered and the filtrate added to 125 ml of hexane. The crystalline material which forms on standing at refrigerator temperature is removed by filtration, washed with light petroleum ether and dried at about 50°C. Approximately 20 g of product are obtained. On recrystallizing from trichloroethylene-hexane, 17.8 g of purified compound are obtained, MP 89° to 91°C.


Brand nameRela (Schering); Soma (Medpointe).
Therapeutic FunctionMuscle relaxant
General DescriptionCarisoprodol, N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate, 2-methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate(Soma), is the mono-N-isopropyl–substituted relative ofmeprobamate. The structure is given in the discussion ofmeprobamate. It is indicated in acute skeletomuscular conditionscharacterized by pain, stiffness, and spasm. As canbe expected, a major side effect of the drug is drowsiness.
Air & Water ReactionsInsoluble in water.
Reactivity ProfileCarisoprodol is a carbamate ester. Carbamates are chemically similar to, but more reactive than amides. Like amides they form polymers such as polyurethane resins. Carbamates are incompatible with strong acids and bases, and especially incompatible with strong reducing agents such as hydrides. Flammable gaseous hydrogen is produced by the combination of active metals or nitrides with carbamates. Strongly oxidizing acids, peroxides, and hydroperoxides are incompatible with carbamates.
Health HazardSYMPTOMS: The most common symptoms of exposure to Carisoprodol are drowsiness and hives. Other symptoms may include nausea, vomiting, epigastric distress, vertigo, ataxia, tremors, agitation, irritability, headache, insomnia, fainting, hiccups, visual disturbances, asthma, fever, hypotension, excitement and paralysis.
Fire HazardFlash point data for Carisoprodol are not available, but Carisoprodol it probably combustible.
SynthesisCarisoprodol, N-iso-propyl-2-methyl-2-propyl-1,3-propanediol (15.3.12), is synthesized by reacting 2-methyl-2-propylpropanediol-1,3 dicarbamate with 1 mol of phosgene, forming the chloroformate (15.3.10), from which carbamate (15.3.11) is formed by reacting it with isopropylamine. Reacting this with either urethane or sodium cyanate gives carisoprodol (15.3.12).

Synthesis_78-44-4

Lorbamate VINYL ESTER RESIN Methylparaben Carisoprodol Carisoprodol, Methyl-D3 Methyl Propyl gallate CARISOPRODOL IMP. C (EP): 2-METHYL-2-PROPYLPROPANE-1,3-DIOL ISOPROPYL LAURATE Nisobamate Carbamic acid, 2,2-dimethylbutyl ester Meprobamate Methanol Tris(hydroxymethyl)nitromethane Propyl butyrate Isopropyl alcohol n-Butyl carbamate CARISOPRODOL IMPURITY A

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.